Biosys Capital

Biosys Capital operates as a venture capital fund, strategically deploying capital into growth-stage companies across various sectors. The firm focuses on identifying and investing in promising ventures that demonstrate significant potential for scale and market disruption, building a diversified portfolio aimed at generating substantial returns for its limited partners. Its approach involves non-controlling equity investments, partnering with portfolio companies to support their expansion and strategic development.

The firm's initial investment committee, instrumental in its formation, included Boris Nikolic, Hayes Nuss, Peter Corsell, and David Schwarz, as outlined in its September 2014 private placement memorandum. This collective brought together diverse expertise, united by the objective of establishing a dedicated fund to capitalize on opportunities within the growth equity landscape, leveraging their backgrounds in finance and industry.

Biosys Capital primarily serves limited partners seeking exposure to high-growth private markets. The firm’s vision centers on cultivating a robust ecosystem of innovative companies, fostering their progress from the growth stage through to successful market presence. It aims to be a key financial and strategic partner, driving long-term value creation for both its investors and the companies it backs.